An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

MLA

Shaila Ballal, et al. An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With MFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f91e80bc246bdfef3d9c7c96bec934b&authtype=sso&custid=ns315887.

APA

Shaila Ballal, Josep Tabernero, Rocio Garcia-Carbonero, Jonathan D. Schwartz, Joan Maurel, Fernando Rivera, Malcolm J. Moore, Jean-Pierre M. Ayoub, Andrés Cervantes, F. Nasroulah, & Timothy R. Asmis. (2014). An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer.

Chicago

Shaila Ballal, Josep Tabernero, Rocio Garcia-Carbonero, Jonathan D. Schwartz, Joan Maurel, Fernando Rivera, Malcolm J. Moore, et al. 2014. “An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With MFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7f91e80bc246bdfef3d9c7c96bec934b&authtype=sso&custid=ns315887.